Sign up for free.Tech news worthy of your timeGet our smart take on technology from the Valley and D.C. Sign up for free.Sports news worthy of your timeBinge on the stats and stories that drive the sports world with Axios Sports. Catch up on what's new and why it matters in just 5 minutes.Catch up on the day's biggest business storiesSubscribe to Axios Closer for insights into the day's business news and trends and why they matterStay on top of the latest market trendsSubscribe to Axios Markets for the latest market trends and economic insights. Sign up for our daily briefingMake your busy days simpler with Axios AM/PM. This disparity in access to vaccines is highlighted by the fact that only 2.3% of individuals in low-income countries have received at least a single dose of the vaccine.
Daniel Grizelj/Getty ImagesThere is an urgent need for effective and readily available antiviral therapies to treat COVID-19.A new study has found that a drug combination involving the antivirals interferon-alpha (IFN-α) and nafamostat effectively combatted SARS-CoV-2 infection.The drug combination inhibited SARS-CoV-2 replication in cell culture and animal studies at lower concentrations than the individual drugs.The higher efficacy of the IFN-α-nafamostat combination at lower concentrations may help reduce side effects and improve patient outcomes.The drug combination produces its antiviral effect by inhibiting a host enzyme instead of a viral protein, potentially reducing the risk of drug resistance.Although high-income nations have achieved high vaccination rates, the unequal distribution of COVID-19 vaccines has left low-income countries struggling to immunize their populations. Share on Pinterest Researchers have been testing several drug combinations to fight off SARS-Cov-2 infection.
Jeffrey Zients (White House Coronavirus Response Coordinator since 2021, selected in 2003), Jeremy Howard (co-founder of lobby group ''masks for all'', selected in 2013), California Governor Gavin Newsom (selected in 2005), Peter Buttigieg (selected in 2019, candidate for US President in 2020, US secretary of transportation since 2021), Chelsea Clinton (Clinton Foundation board member), Huma Abedin (Hillary Clinton aide, selected in 2012), Nikki Haley (US ambassador to the UN, 2017-2018), Samantha Power (US ambassador to the UN, 2013-2017, USAID Administrator since 2021), Ian Bremmer (founder of Eurasia Group), Bill Browder (initiator of the Magnitsky Act), Jonathan Soros (son of George Soros), Kenneth Roth (director of ''Human Rights Watch'' since 1993), Paul Krugman (economist, selected in 1995), Lawrence Summers (former World Bank Chief Economist, former US Treasury Secretary, former Harvard University President, selected in 1993), Alicia Garza (co-founder of Black Lives Matter, selected in 2020), St(C)phane Bancel (Moderna CEO). Jeffrey Zients (White House Coronavirus Response Coordinator since 2021, selected in 2003), Jeremy Howard (co-founder of lobby group “masks for all”, selected in 2013), California Governor Gavin Newsom (selected in 2005), Peter Buttigieg (selected in 2019, candidate for US President in 2020, US secretary of transportation since 2021), Chelsea Clinton (Clinton Foundation board member), Huma Abedin (Hillary Clinton aide, selected in 2012), Nikki Haley (US ambassador to the UN, 2017-2018), Samantha Power (US ambassador to the UN, 2013-2017, USAID Administrator since 2021), Ian Bremmer (founder of Eurasia Group), Bill Browder (initiator of the Magnitsky Act), Jonathan Soros (son of George Soros), Kenneth Roth (director of “Human Rights Watch” since 1993), Paul Krugman (economist, selected in 1995), Lawrence Summers (former World Bank Chief Economist, former US Treasury Secretary, former Harvard University President, selected in 1993), Alicia Garza (co-founder of Black Lives Matter, selected in 2020), Stéphane Bancel (Moderna CEO).